Level Biotechnology Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 141.55 million compared to TWD 173.71 million a year ago. Net income was TWD 13.4 million compared to TWD 18.46 million a year ago. Basic earnings per share from continuing operations was TWD 0.41 compared to TWD 0.57 a year ago. Diluted earnings per share from continuing operations was TWD 0.41 compared to TWD 0.57 a year ago.
For the nine months, sales was TWD 409.83 million compared to TWD 518.07 million a year ago. Net income was TWD 41.21 million compared to TWD 52.49 million a year ago. Basic earnings per share from continuing operations was TWD 1.27 compared to TWD 1.62 a year ago. Diluted earnings per share from continuing operations was TWD 1.26 compared to TWD 1.61 a year ago.